Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 5, 2025
Deals

Chimerix’s alignment with FDA on submission drives $935M takeout by Jazz

Building in oncology, Jazz obtains targeted glioma therapy under FDA review
BioCentury | May 31, 2019
Translation in Brief

New target for Oncoceutics' GPCR-targeting compounds

Oncoceutics' compounds increase mitochondrial protease activity to kill cancer
Items per page:
1 - 2 of 2